Krensavage Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.9M Buy
472,376
+40,390
+9% +$1.27M 7.88% 6
2025
Q1
$14.1M Buy
+431,986
New +$14.1M 7.82% 4